| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7861662 | Journal of Controlled Release | 2016 | 29 Pages |
Abstract
D-PNA100 nanomedicines are co-assembled by mixing PNA100 and doxorubicin hydrocloride (DOX·HCl). The co-assembly, along with temperature-sensitive sol-gel transition, play important role on prolonging retention time in tumor.411
Keywords
Related Topics
Physical Sciences and Engineering
Materials Science
Biomaterials
Authors
Jiangshan Wan, Shinan Geng, Hao Zhao, Xiaole Peng, Qing Zhou, Han Li, Ming He, Yanbing Zhao, Xiangliang Yang, Huibi Xu,